Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

October 1999

Volume 883 CHARCOT-MARIE-TOOTH DISORDERS

Pages xiii–xviii, 1–539

  1. Frontmatter

    1. Top of page
    2. Frontmatter
    3. Charcot-Marie-Tooth Disordersa: Part I. Clinical and Pathological Review of What Constitutes CMT
    4. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    5. Article: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    6. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    7. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session B. Molecules Involved in the Pathogenesis of CMT1
    8. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session C. Schwann Cell Cultures and Studies of Myelination
    9. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session D. Mouse and Rat Models in Studies of CMT
    10. Charcot-Marie-Tooth Disordersa: Part III. Genotype/Phenotype Correlations in Charcot-Marie-Tooth
    11. Charcot-Marie-Tooth Disordersa: Part IV. Diagnosis and Therapy of Charcot-Marie-Tooth
    12. Charcot-Marie-Tooth Disordersa: Part V. Poster Papers
    1. Introduction to the Third International Symposium on Charcot-Marie-Tooth Disorders (pages xiii–xviii)

      MICHAEL E. SHY, JOHN KAMHOLZ and ROBERT E. LOVELACE

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08559.x

  2. Charcot-Marie-Tooth Disordersa: Part I. Clinical and Pathological Review of What Constitutes CMT

    1. Top of page
    2. Frontmatter
    3. Charcot-Marie-Tooth Disordersa: Part I. Clinical and Pathological Review of What Constitutes CMT
    4. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    5. Article: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    6. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    7. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session B. Molecules Involved in the Pathogenesis of CMT1
    8. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session C. Schwann Cell Cultures and Studies of Myelination
    9. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session D. Mouse and Rat Models in Studies of CMT
    10. Charcot-Marie-Tooth Disordersa: Part III. Genotype/Phenotype Correlations in Charcot-Marie-Tooth
    11. Charcot-Marie-Tooth Disordersa: Part IV. Diagnosis and Therapy of Charcot-Marie-Tooth
    12. Charcot-Marie-Tooth Disordersa: Part V. Poster Papers
    1. Overview of Charcot-Marie-Tooth Disease Type 1A (pages 1–5)

      P. K. THOMAS

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08560.x

    2. Molecular Mechanisms for CMT1A Duplication and HNPP Deletion (pages 22–35)

      C. F. BOERKOEL, K. INOUE, L. T. REITER, L. E. WARNER and J. R. LUPSKI

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08563.x

    3. X-linked Charcot-Marie-Tooth Disease and Connexin32 (pages 36–41)

      KENNETH H. FISCHBECK, ANNETTE ABEL, GRACE S. LIN and STEVEN S. SCHERER

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08564.x

    4. Charcot-Marie-Tooth Disease Type 2 (pages 42–46)

      JEFFERY M. VANCE

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08565.x

    5. Autosomal Recessive Hereditary Motor and Sensory Neuropathy with Focally Folded Myelin Sheaths (CMT4B) (pages 47–55)

      ANTONIO GAMBARDELLA, FRANCESCO BONO, MARIELLA MUGLIA, PAOLA VALENTINO and ALDO QUATTRONE

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08566.x

    6. The Autosomal Recessive Form of CMT Disease Linked to 5q31-q33 (pages 56–59)

      A. GUILBOT, M. KESSALI, N. RAVISÉ, T. HAMMADOUCHE, A. BOUHOUCHE, T. MAISONOBE, D. GRID, A. BRICE and E. LEGUERN

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08567.x

    7. Distal Hereditary Motor Neuropathy Type II (Distal HMN Type II): Phenotype and Molecular Genetics (pages 60–64)

      V. TIMMERMAN, J. BEUTEN, J. IROBI, P. De JONGHE, J.-J. MARTIN and C. VAN BROECKHOVEN

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08568.x

    8. Distal Hereditary Motor Neuronopathy of the Jerash Type (pages 65–68)

      L. T. MIDDLETON, K. CHRISTODOULOU, A. MUBAIDIN, E. ZAMBA, M. TSINGIS, K. KYRIACOU, S. ABU-SHEIKH, T. KYRIAKIDES, V. NEOCLEOUS, D. M. GEORGIOU, M. EL-KHATEEB, A. AL-QUDAN and K. HORANY

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08569.x

    9. A Clinical Review of Charcot-Marie-Tooth (pages 69–76)

      CARLOS A. GARCIA

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08570.x

    10. Schwann Cell-Axon Interactions in Charcot-Marie-Tooth Disease (pages 77–90)

      JOHN W. GRIFFIN and KAZIM SHEIKH

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08571.x

  3. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination

    1. Top of page
    2. Frontmatter
    3. Charcot-Marie-Tooth Disordersa: Part I. Clinical and Pathological Review of What Constitutes CMT
    4. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    5. Article: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    6. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    7. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session B. Molecules Involved in the Pathogenesis of CMT1
    8. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session C. Schwann Cell Cultures and Studies of Myelination
    9. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session D. Mouse and Rat Models in Studies of CMT
    10. Charcot-Marie-Tooth Disordersa: Part III. Genotype/Phenotype Correlations in Charcot-Marie-Tooth
    11. Charcot-Marie-Tooth Disordersa: Part IV. Diagnosis and Therapy of Charcot-Marie-Tooth
    12. Charcot-Marie-Tooth Disordersa: Part V. Poster Papers
    1. Regulation of Myelin-Specific Gene Expression: Relevance to CMT1 (pages 91–108)

      JOHN KAMHOLZ, RAJ AWATRAMANI, DANIELA MENICHELLA, HUIYUAN JIANG, WENBO XU and MICHAEL SHY

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08572.x

  4. Article: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination

    1. Top of page
    2. Frontmatter
    3. Charcot-Marie-Tooth Disordersa: Part I. Clinical and Pathological Review of What Constitutes CMT
    4. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    5. Article: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    6. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    7. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session B. Molecules Involved in the Pathogenesis of CMT1
    8. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session C. Schwann Cell Cultures and Studies of Myelination
    9. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session D. Mouse and Rat Models in Studies of CMT
    10. Charcot-Marie-Tooth Disordersa: Part III. Genotype/Phenotype Correlations in Charcot-Marie-Tooth
    11. Charcot-Marie-Tooth Disordersa: Part IV. Diagnosis and Therapy of Charcot-Marie-Tooth
    12. Charcot-Marie-Tooth Disordersa: Part V. Poster Papers
    1. Why Do Schwann Cells Survive in the Absence of Axons? (pages 109–115)

      K. R. JESSEN and R. MIRSKY

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08573.x

  5. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination

    1. Top of page
    2. Frontmatter
    3. Charcot-Marie-Tooth Disordersa: Part I. Clinical and Pathological Review of What Constitutes CMT
    4. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    5. Article: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    6. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    7. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session B. Molecules Involved in the Pathogenesis of CMT1
    8. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session C. Schwann Cell Cultures and Studies of Myelination
    9. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session D. Mouse and Rat Models in Studies of CMT
    10. Charcot-Marie-Tooth Disordersa: Part III. Genotype/Phenotype Correlations in Charcot-Marie-Tooth
    11. Charcot-Marie-Tooth Disordersa: Part IV. Diagnosis and Therapy of Charcot-Marie-Tooth
    12. Charcot-Marie-Tooth Disordersa: Part V. Poster Papers
    1. P0-Cre Transgenic Mice for Inactivation of Adhesion Molecules in Schwann Cells (pages 116–123)

      MARIA LAURA FELTRI, MAURIZIO D'ANTONIO, STEFANO PREVITALI, MARINA FASOLINI, ALBEE MESSING and LAWRENCE WRABETZ

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08574.x

    2. IGF-I Promotes Peripheral Nervous System Myelination (pages 124–130)

      HSIN-LIN CHENG, JAMES W. RUSSELL and EVA L. FELDMAN

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08575.x

    3. Nodes, Paranodes, and Incisures: From Form to Function (pages 131–142)

      STEVEN S. SCHERER

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08576.x

  6. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session B. Molecules Involved in the Pathogenesis of CMT1

    1. Top of page
    2. Frontmatter
    3. Charcot-Marie-Tooth Disordersa: Part I. Clinical and Pathological Review of What Constitutes CMT
    4. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    5. Article: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    6. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    7. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session B. Molecules Involved in the Pathogenesis of CMT1
    8. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session C. Schwann Cell Cultures and Studies of Myelination
    9. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session D. Mouse and Rat Models in Studies of CMT
    10. Charcot-Marie-Tooth Disordersa: Part III. Genotype/Phenotype Correlations in Charcot-Marie-Tooth
    11. Charcot-Marie-Tooth Disordersa: Part IV. Diagnosis and Therapy of Charcot-Marie-Tooth
    12. Charcot-Marie-Tooth Disordersa: Part V. Poster Papers
    1. The Anatomy and Cell Biology of Peripheral Myelin Protein-22 (pages 143–151)

      G. JACKSON SNIPES, WAYEL ORFALI, ANDREW FRASER, KATHLEEN DICKSON and JOSHUA COLBY

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08577.x

    2. Characterization of the Effect on Adhesion of Different Mutations in Myelin P0 Protein (pages 160–167)

      MARIE T. FILBIN, KEJIA ZHANG, WENHUI LI and YING GAO

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08579.x

    3. Ultrastructural Immunocytochemical Abnormalities of Peripheral Myelin Proteins in Hereditary Sensory-Motor Neuropathies: 12 cases (pages 186–195)

      THIERRY ANANI, PHILIPPE SINDOU, LAURENCE RICHARD, MARTINE DIOT and JEAN-MICHEL VALLAT

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08581.x

  7. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session C. Schwann Cell Cultures and Studies of Myelination

    1. Top of page
    2. Frontmatter
    3. Charcot-Marie-Tooth Disordersa: Part I. Clinical and Pathological Review of What Constitutes CMT
    4. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    5. Article: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    6. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    7. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session B. Molecules Involved in the Pathogenesis of CMT1
    8. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session C. Schwann Cell Cultures and Studies of Myelination
    9. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session D. Mouse and Rat Models in Studies of CMT
    10. Charcot-Marie-Tooth Disordersa: Part III. Genotype/Phenotype Correlations in Charcot-Marie-Tooth
    11. Charcot-Marie-Tooth Disordersa: Part IV. Diagnosis and Therapy of Charcot-Marie-Tooth
    12. Charcot-Marie-Tooth Disordersa: Part V. Poster Papers
    1. Schwann Cell-Derived Desert Hedgehog Signals Nerve Sheath Formation (pages 196–202)

      RHONA MIRSKY, ERIC PARMANTIER, ANDREW P. MCMAHON and KRISTJAN R. JESSEN

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08582.x

    2. Neurofibromin, the Neurofibromatosis Type 1 Ras-GAP, Is Required for Appropriate P0 Expression and Myelination (pages 203–214)

      THORSTEN ROSENBAUM, HAESUN A. KIM, YING L. BOISSY, BO LING and NANCY RATNER

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08583.x

    3. The Biology of Chronically Denervated Schwann Cells (pages 215–233)

      SUSAN M. HALL

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08584.x

  8. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session D. Mouse and Rat Models in Studies of CMT

    1. Top of page
    2. Frontmatter
    3. Charcot-Marie-Tooth Disordersa: Part I. Clinical and Pathological Review of What Constitutes CMT
    4. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    5. Article: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    6. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    7. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session B. Molecules Involved in the Pathogenesis of CMT1
    8. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session C. Schwann Cell Cultures and Studies of Myelination
    9. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session D. Mouse and Rat Models in Studies of CMT
    10. Charcot-Marie-Tooth Disordersa: Part III. Genotype/Phenotype Correlations in Charcot-Marie-Tooth
    11. Charcot-Marie-Tooth Disordersa: Part IV. Diagnosis and Therapy of Charcot-Marie-Tooth
    12. Charcot-Marie-Tooth Disordersa: Part V. Poster Papers
    1. Distinct Phenotypes Associated with Increasing Dosage of the PLP Gene: Implications for CMT1A Due to PMP22 Gene Duplication (pages 234–246)

      T. J. ANDERSON, M. KLUGMANN, C. E. THOMSON, A. SCHNEIDER, C. READHEAD, K-A. NAVE and I. R. GRIFFITHS

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08585.x

    2. Transgenic Mouse Models of CMT1A and HNPP (pages 247–253)

      UELI SUTER and KLAUS-ARMIN NAVE

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08586.x

    3. The “CMT Rat”: Peripheral Neuropathy and Dysmyelination Caused by Transgenic Overexpression of PMP22 (pages 254–261)

      STEPHAN NIEMANN, MICHAEL W. SEREDA, MORITZ ROSSNER, HELEN STEWART, UELI SUTER, HANS-MICHAEL MEINCK, IAN R. GRIFFITHS and KLAUS-ARMIN NAVE

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08587.x

    4. Trembler as a Mouse Model of CMT1A? (pages 262–272)

      BERTRAND GARBAY, JEROME SALLES, ANJA KNOLL, FRANÇOISE BOIRON-SARGUEIL, ANTHONY M. HEAPE, JACQUES BONNET and CLAUDE CASSAGNE

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08588.x

    5. The Absence of Myelin P0 Protein Produces a Novel Molecular Phenotype in Schwann Cell (pages 281–293)

      DANIELA MARIA MENICHELLA, WENBO XU, HUIYUAN JIANG, JASLOVELEEN SOHI, JEAN-MICHAEL VALLAT, PIERLUIGI BARON, JOHN KAMHOLZ and MICHAEL SHY

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08590.x

    6. Peripheral Nerve Dysmyelination Due to P0 Glycoprotein Overexpression Is Dose-Dependent (pages 294–301)

      ANGELO QUATTRINI, MARIA LAURA FELTRI, STEFANO PREVITALI, MARINA FASOLINI, ALBEE MESSING and LAWRENCE WRABETZ

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08591.x

    7. Characterization of Targeted Connexin32-Deficient Mice: A Model for the Human Charcot-Marie-Tooth (X-Type) Inherited Disease (pages 302–309)

      KLAUS WILLECKE, ACHIM TEMME, BARBARA TEUBNER and THOMAS OTT

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08592.x

  9. Charcot-Marie-Tooth Disordersa: Part III. Genotype/Phenotype Correlations in Charcot-Marie-Tooth

    1. Top of page
    2. Frontmatter
    3. Charcot-Marie-Tooth Disordersa: Part I. Clinical and Pathological Review of What Constitutes CMT
    4. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    5. Article: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    6. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    7. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session B. Molecules Involved in the Pathogenesis of CMT1
    8. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session C. Schwann Cell Cultures and Studies of Myelination
    9. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session D. Mouse and Rat Models in Studies of CMT
    10. Charcot-Marie-Tooth Disordersa: Part III. Genotype/Phenotype Correlations in Charcot-Marie-Tooth
    11. Charcot-Marie-Tooth Disordersa: Part IV. Diagnosis and Therapy of Charcot-Marie-Tooth
    12. Charcot-Marie-Tooth Disordersa: Part V. Poster Papers
    1. Electrophysiologic Features of Inherited Demyelinating Neuropathies: A Reappraisal (pages 321–335)

      RICHARD A. LEWIS and AUSTIN J. SUMNER

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08594.x

    2. Human Nerve Pathology Caused by Different Mutational Mechanisms of the PMP22 Gene (pages 336–343)

      ANNEKE GABREËLS-FESTEN and RUDI VAN DE WETERING

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08595.x

    3. Peripheral Neuropathy Caused by Proteolipid Protein Gene Mutations (pages 351–365)

      JAMES Y. GARBERN, FRANCA CAMBI, RICHARD LEWIS, MICHAEL SHY, ANDERS SIMA, GEORGE KRAFT, J. M. VALLAT, E. P. BOSCH, M. E. HODES, STEPHEN DLOUHY, WENDY RASKIND, THOMAS BIRD, WENDY MACKLIN and JOHN KAMHOLZ

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08597.x

    4. Genotype/Phenotype Correlations in X-Linked Dominant Charcot-Marie-Tooth Disease (pages 366–382)

      ANGELIKA F. HAHN, CHARLES F. BOLTON, CHRISTOPHER M. WHITE, WILLIAM F. BROWN, SASCHA E. TUUHA, CHARLES C. TAN and PETER J. AINSWORTH

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08598.x

  10. Charcot-Marie-Tooth Disordersa: Part IV. Diagnosis and Therapy of Charcot-Marie-Tooth

    1. Top of page
    2. Frontmatter
    3. Charcot-Marie-Tooth Disordersa: Part I. Clinical and Pathological Review of What Constitutes CMT
    4. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    5. Article: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    6. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    7. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session B. Molecules Involved in the Pathogenesis of CMT1
    8. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session C. Schwann Cell Cultures and Studies of Myelination
    9. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session D. Mouse and Rat Models in Studies of CMT
    10. Charcot-Marie-Tooth Disordersa: Part III. Genotype/Phenotype Correlations in Charcot-Marie-Tooth
    11. Charcot-Marie-Tooth Disordersa: Part IV. Diagnosis and Therapy of Charcot-Marie-Tooth
    12. Charcot-Marie-Tooth Disordersa: Part V. Poster Papers
    1. Mutation Testing in Charcot-Marie-Tooth Neuropathy (pages 383–388)

      GARTH A. NICHOLSON

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08599.x

    2. Molecular Diagnostic Testing in Charcot-Marie-Tooth Disease and Related Disorders: Approaches and Results (pages 389–396)

      P. De JONGHE, E. NELIS, V. TIMMERMAN, A. LÖFGREN, J-J. MARTIN and C. VAN BROECKHOVEN

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08600.x

    3. Overcoming Cellular Immunity to Prolong Adenoviral-Mediated Gene Expression in Sciatic Nerve (pages 397–414)

      AGNES JANI, DANIELA MENICHELLA, HUIYUAN JIANG, TAIBI CHBIHI, GYULA ACSADI, JOHN KAMHOLZ and MICHAEL E. SHY

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08601.x

    4. Trophic Factors in Neuron-Schwann Cell Interactions (pages 427–438)

      H.C. HYMAN FRIEDMAN, A. J. AGUAYO and G. M. BRAY

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08603.x

  11. Charcot-Marie-Tooth Disordersa: Part V. Poster Papers

    1. Top of page
    2. Frontmatter
    3. Charcot-Marie-Tooth Disordersa: Part I. Clinical and Pathological Review of What Constitutes CMT
    4. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    5. Article: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    6. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session A. Schwann Cell-Axonal Interactions and the Program of PNS Myelination
    7. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session B. Molecules Involved in the Pathogenesis of CMT1
    8. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session C. Schwann Cell Cultures and Studies of Myelination
    9. Charcot-Marie-Tooth Disordersa: Part II. Pathogenesis of Demyelination in CMT: Session D. Mouse and Rat Models in Studies of CMT
    10. Charcot-Marie-Tooth Disordersa: Part III. Genotype/Phenotype Correlations in Charcot-Marie-Tooth
    11. Charcot-Marie-Tooth Disordersa: Part IV. Diagnosis and Therapy of Charcot-Marie-Tooth
    12. Charcot-Marie-Tooth Disordersa: Part V. Poster Papers
    1. Distal Hereditary Motor Neuronopathy of the Jerash Type (pages 439–442)

      L. T. MIDDLETON, K. CHRISTODOULOU, A. MUBAIDIN, E. ZAMBA, M. TSINGIS, K. KYRIACOU, S. ABU-SHEIKH, T. KYRIAKIDES, V. NEOCLEOUS, D. M. GEORGIOU, M. EL-KHATEEB, A. AL-QUDAH and K. HORANY

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08604.x

    2. Hereditary Neuralgic Amyotrophy: Mutation Analysis of Candidate Genes (pages 443–444)

      J. MEULEMAN, G. KUHLENBÄUMER, A. SCHIRMACHER, M. WEHNERT, P. YOUNG, F. STÖGBAUER, E. B. RINGELSTEIN, C. VAN BROECKHOVEN and V. TIMMERMAN

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08605.x

    3. A Second Family with Autosomal Dominant Burning Feet Syndrome (pages 445–448)

      G. KUHLENBÄUMER, P. YOUNG, R. KIEFER, V. TIMMERMAN, J.-F. WANG, J. M. SCHROEDER, J. WEIS, E. B. RINGELSTEIN, C. VAN BROECKHOVEN and F. STOEGBAUER

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08606.x

    4. Hereditary Motor and Sensory Neuropathy with Proximal Dominant Involvement: Clinical, Pathological, and Genetic Features (pages 449–452)

      MASANORI NAKAGAWA, HIROSHI TAKASHIMA, MASAHITO SUEHARA, MINEKI SAITO, AKIKO SAITO, NAOMI KANZATO, TOSHIO MATSUZAKI, KEIKO HIRATA, SHUJI IZUMO, JOSEPH D. TERWILLIGER and MITSUHIRO OSAME

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08607.x

    5. The Autosomal Recessive Form of CMT Disease Linked to 5q31-q33 (pages 453–456)

      A. GUILBOT, M. KESSALI, N. RAVISÉ, T. HAMMADOUCHE, A. BOUHOUCHE, T. MAISONOBE, D. GRID, A. BRICE and E. LeGUERN

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08608.x

    6. Prenatal Diagnosis of Charcot-Marie-Tooth Disease Type 1A (pages 457–459)

      CATHERINE D. KASHORK, KEN-SHIUNG CHEN, JAMES R. LUPSKI and LISA G. SHAFFER

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08609.x

    7. Preimplantation Diagnosis for Charcot-Marie-Tooth Type 1A (pages 460–462)

      A. LÖFGREN, A. De VOS, K. SERMON, I. LIEBAERS, A. VAN STEIRTEGHEM and C. VAN BROECKHOVEN

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08610.x

    8. Construction of a PAC Contig within the Distal Hereditary Motor Neuropathy Type II Candidate Region at 12q24 (pages 463–465)

      JOY IROBI, VINCENT TIMMERMAN, PETER De JONGHE, ELS De VRIENDT, CHRISTINE VAN BROECKHOVEN and J. BEUTEN

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08611.x

    9. A Family with Friedreich Ataxia and Onion-Bulb Formations at Sural Nerve Biopsy (pages 466–468)

      A. A. BARREIRA, W. MARQUES JR., M. G. SWEENEY, M. B. DAVIS, L. CHIMELLI, M. L. PAÇÓ-LARSON and N. W. WOOD

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08612.x

    10. Proximal Charcot-Marie-Tooth Syndrome with Duplication on Chromosome 17p11.2 (pages 469–471)

      MICHAELA AUER-GRUMBACH, KLAUS WAGNER, FRANZ PAYER and HANS-PETER HARTUNG

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08613.x

    11. Modification of CMT1 Phenotypes by the Independent Coexisting Neurogenetic Disorders, McArdle Disease and Chromosome 5p Trisomy (pages 472–476)

      FLORIAN P. THOMAS, THOMAS J. GELLER, ANGELIKA F. HAHN, LUDWIG GUTMANN, XIN-LI HUANG, HUI WU, HERMAN E. WYANDT and ROGER V. LEBO

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08614.x

    12. Heterozygous Null Mutation in the P0 Gene Associated with Mild Charcot-Marie-Tooth Disease (pages 477–480)

      D. PAREYSON, D. MENICHELLA, S. BOTTI, A. SGHIRLANZONI, E. FALLICA, M. MORA, C. CIANO, M. E. SHY and F. TARONI

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08615.x

    13. A Unique Mutation in Connexin32 Associated with Severe, Early Onset CMTX in a Heterozygous Female (pages 481–484)

      GRACE S. LIN, JONATHAN D. GLASS, SUSAN SHUMAS, STEVEN S. SCHERER and KENNETH H. FISCHBECK

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08616.x

    14. Charcot-Marie-Tooth 1A: Heterozygous T118M Mutation over a CMT1A Duplication Has No Influence on the Phenotype (pages 485–489)

      P. SEEMAN, R. MAZANEC, T. MARIKOVA and B. RAUTENSTRAUSS

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08617.x

    15. Correlation between Weakness and Axonal Loss in Patients with CMT1A (pages 490–492)

      KAREN KRAJEWSKI, CHERYL TURANSKY, RICHARD LEWIS, JAMES GARBERN, STEVEN HINDERER, JOHN KAMHOLZ and MICHAEL E. SHY

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08618.x

    16. Mutation Screening of Charcot-Marie-Tooth Patients in Poland (pages 493–496)

      A. KOCHAŃSKI, V. TIMMERMAN, H. JEDRZEJOWSKA, B. RYNIEWICZ, A. LÖFGREN, E. De VRIENDT, C. VAN BROECKHOVEN, A. LATOS-BIELEŃSKA and I. HAUSMANOWA-PETRUSEWICZ

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08619.x

    17. Phenotypic Manifestations in French-Canadian Population with Charcot-Marie-Tooth Disease Type 1A Associated with 17p11.2 Duplication (pages 497–499)

      NICOLAS DUPRÉ, JEAN-PIERRE BOUCHARD, LOUISE COSSETTE, DENIS BRUNET, MICHEL VANASSE, BERNARD LEMIEUX, GILLES MATHON and JACK PUYMIRAT

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08620.x

    18. HMSN and HNPP: Laboratory Service Provision in the South West of England-Two Years' Experience (pages 500–503)

      M. M. WILLIAMS, L. A. TYFIELD, P. JARDINE, P. W. LUNT, D. L. STEVENS and P. D. TURNPENNY

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08621.x

    19. Induction of Myelin Gene Expression in Murine Schwann Cells in Primary Culture and in a Schwann Cell Line (pages 513–517)

      S. M. NICHOLSON, D. GOMÈS, A. BARON-VAN EVERCOOREN and R. BRUZZONE

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08624.x

    20. Schwann Cell Apoptosis during Cell-Mediated Demyelination (pages 518–519)

      G. CONTI, E. SCARPINI, A. ROSTAMI, S. LIVRAGHI, R. CLERICI, L. PICCIO, I. SIGLIENTI, P. L. BARON, D. PLEASURE and G. SCARLATO

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08625.x

    21. Human Schwann Cell Proliferation and IL-6 Production following TNF-α Stimulation in Vitro (pages 520–522)

      E. SCARPINI, G. C. CONTI, S. BUSSINI, R. CLERICI, I. SIGLIENTI, L. PICCIO, A. De POL, P. L. BARON and G. SCARLATO

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08626.x

    22. Altered Assembly of Gap Junction Channels Caused by COOH-Terminal Connexin32 Mutants of CMTX (pages 526–529)

      LUIS C. BARRIO, CARMEN CASTRO and JUAN M. GÓMEZ-HERNANDEZ

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08628.x

    23. Characteristics of Gap Junction Channels in Schwann Cells from Wild-Type and Connexin-Null Mice (pages 533–537)

      SHUMIN ZHAO, ALFREDO FORT and DAVID C. SPRAY

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08630.x

    24. MBP-lacZ Transgene Expression in Juvenile and Adult Trembler-J Mice (pages 538–539)

      HOOMAN F. FARHADI, REZA FORGHANI and ALAN C. PETERSON

      Version of Record online: 6 FEB 2006 | DOI: 10.1111/j.1749-6632.1999.tb08631.x

SEARCH

SEARCH BY CITATION